Financial Services
M&A Advisory
Technology
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Royalty Pharmaceuticals. United States. Announced Date 18/08/2011. Closed Date 09/08/2011. Deal value: $3600m. Royalty Pharma recapitalizes $3.6 billion of debt and provides a one-time distribution of $850 million to its investors. Industry: Royalty Pharmaceuticals operates in the pharmaceutical industry, specializing in acquiring pharmaceutical royalties.